|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4331647A
(en)
|
1980-03-03 |
1982-05-25 |
Goldenberg Milton David |
Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US4751180A
(en)
|
1985-03-28 |
1988-06-14 |
Chiron Corporation |
Expression using fused genes providing for protein product
|
|
DE3675588D1
(de)
|
1985-06-19 |
1990-12-20 |
Ajinomoto Kk |
Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
|
|
US4935233A
(en)
|
1985-12-02 |
1990-06-19 |
G. D. Searle And Company |
Covalently linked polypeptide cell modulators
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5011912A
(en)
|
1986-12-19 |
1991-04-30 |
Immunex Corporation |
Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
|
|
US5262522A
(en)
|
1991-11-22 |
1993-11-16 |
Immunex Corporation |
Receptor for oncostatin M and leukemia inhibitory factor
|
|
ATE240394T1
(de)
|
1992-10-23 |
2003-05-15 |
Immunex Corp |
Methoden zur herstellung löslicher, oligomerer proteine
|
|
US5457035A
(en)
|
1993-07-23 |
1995-10-10 |
Immunex Corporation |
Cytokine which is a ligand for OX40
|
|
US6133426A
(en)
|
1997-02-21 |
2000-10-17 |
Genentech, Inc. |
Humanized anti-IL-8 monoclonal antibodies
|
|
JP3614866B2
(ja)
|
1997-06-12 |
2005-01-26 |
リサーチ コーポレイション テクノロジーズ，インコーポレイティド |
人工抗体ポリペプチド
|
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
|
US6210924B1
(en)
|
1998-08-11 |
2001-04-03 |
Amgen Inc. |
Overexpressing cyclin D 1 in a eukaryotic cell line
|
|
GB9928787D0
(en)
|
1999-12-03 |
2000-02-02 |
Medical Res Council |
Direct screening method
|
|
GB0025144D0
(en)
|
2000-10-13 |
2000-11-29 |
Medical Res Council |
Concatenated nucleic acid sequences
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US20040202995A1
(en)
|
2003-04-09 |
2004-10-14 |
Domantis |
Nucleic acids, proteins, and screening methods
|
|
BRPI0708507A2
(pt)
|
2006-03-03 |
2011-05-31 |
Torrent Pharmaceuticals Ltd |
Novos antagonistas de receptores de dupla ação (dara) para os receptores at1 eta
|
|
UA109888C2
(uk)
*
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
|
KR20140022048A
(ko)
|
2011-05-25 |
2014-02-21 |
인터뮨, 인크. |
선택된 환자에서의 피르페니돈 및 항-섬유성 치료제
|
|
CN104371019B
(zh)
*
|
2013-08-13 |
2019-09-10 |
鸿运华宁（杭州）生物医药有限公司 |
一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质
|
|
EP4417255A3
(en)
|
2013-11-21 |
2024-10-23 |
The Brigham and Women's Hospital Inc. |
Compositions and methods for treating pulmonary hypertension
|
|
EP3105246B1
(en)
|
2014-02-10 |
2021-03-31 |
Merck Patent GmbH |
Targeted tgf beta inhibition
|
|
US9750761B2
(en)
*
|
2014-05-21 |
2017-09-05 |
University Of Rochester |
LDH inhibitors as treatment for fibrosis and fibrotic-related disorders
|
|
CN105669863B
(zh)
|
2014-12-05 |
2019-09-13 |
鸿运华宁（杭州）生物医药有限公司 |
一种能与人内皮素受体特异性结合的抗体及其应用
|
|
CA2996996A1
(en)
|
2015-08-31 |
2017-03-09 |
National Research Council Of Canada |
Tgf-.beta.-receptor ectodomain fusion molecules and uses thereof
|
|
WO2017049251A2
(en)
*
|
2015-09-18 |
2017-03-23 |
Tioma Therapeutics, Inc. |
Therapeutic cd47 antibodies
|
|
UA125062C2
(uk)
*
|
2015-10-01 |
2022-01-05 |
Потенза Терапеутікс, Інк. |
Анти-tigit антигензв'язуючі білки і способи їх застосування
|
|
TWI826351B
(zh)
|
2016-05-31 |
2023-12-21 |
大陸商鴻運華寧（杭州）生物醫藥有限公司 |
Ｒ抗體,其藥物組合物及其應用
|
|
CN107987162A
(zh)
*
|
2016-10-27 |
2018-05-04 |
鸿运华宁（杭州）生物医药有限公司 |
Etar抗体，其药物组合物及其应用
|
|
EP3500302A4
(en)
|
2016-08-16 |
2020-03-25 |
University of Maryland, Baltimore |
METHODS OF TREATING CANCER WITH BIFUNCTIONAL MOLECULES TARGETING GROWTH FACTORS
|
|
BR112019023071A2
(pt)
|
2017-05-04 |
2020-06-09 |
Acceleron Pharma Inc |
proteínas de fusão do receptor tgf-beta do tipo ii e uso das mesmas
|